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Colloquium Discusses Development of a New Diabetes Treatment  
BLOOMINGTON, Ill. – Illinois Wesleyan University Professor Ram Mohan will host a 
science colloquium on Friday, Oct. 3 at 4 p.m. in room C101 of the Center for Natural Science 
Learning and Research (201 E. Beecher St. Bloomington). 
The presentation is free and open to the public. 
The colloquium, titled “Identification and Development of a Novel Diabetes Treatment” 
will feature guest speaker Dr. Steven Tymonko a 2001 IWU alumnus who works for the global 
pharmaceutical company Bristol-Myers Squibb. 
The presentation will highlight the chemical development of a drug currently being tested 
for use as a diabetes treatment. Specifically, Tymonko will focus on the synthesis of the 
compound found in the drug and the difficulties in preparing it on a large scale.  
Tymonko received his doctorate in synthetic organic chemistry from the University of 
Illinois at Urbana, Champaign in 2007 and is currently working in the process development 
group of Bristol-Myers Squibb on the synthesis of potential drug candidates. 
For additional information, contact Professor Ram Mohan at (309) 556-3829. 
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